The use of HDAC6 inhibitor tubastatin A in vivo can protect dogs with atrial tachycardia pacing from electrical remodeling, while the dominant negative HDAC6 mutant can completely rescue the systolic dysfunction induced by tachycardia pacing (23). Here, HDAC6 is linked to atrial tachycardia.